Next, we demonstrated that transcript levels of NOTCH pathway members NOTCH1, NOTCH4, DLL1 and HES-1, which carry METTL3-dependent m6A peaks, were downregulated in METTL3-silenced glioma cells (Figure 6C, Table 1). This evidence concerns the gene HES1 and central nervous system cancer.